Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company The Rockefeller University
DescriptionHumanized anti-CD4 binding site mAb
Molecular Target CD4
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV-1 infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today